 III. To determine the maximally tolerated dose of proton radiotherapy for patients with potentially resectable retroperitoneal sarcoma. Pre-operative cohort IV. To assess acute side effects from irradiation using proton beam therapy and dosevolume constraints that are derived from conventional radiotherapy. Postoperative cohort 